UT Health San Antonio finds higher levels of leptin indicate brain protection against late-life dementia

September 18, 2024

Weight-maintaining hormone key to brain-signal transmission New research is more closely linking obesity to dementia. Higher levels of leptin, a hormone that helps maintain normal body weight, is associated with better signal-transmitting brain white matter in middle-aged adults, according to a study by The University of Texas Health Science Center at San Antonio (UT Health […]




UT Health San Antonio finds genetic risk-factor overlap between Alzheimer’s disease, and all-cause and vascular dementias

September 17, 2024

  In landmark research, scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have reported the largest-ever genome-wide association study of dementia from all causes, revealing an overlap of genetic risks including neurodegeneration, vascular factors and cerebral small-vessel disease. Genome-wide association studies help scientists identify genes associated with […]




UT Health San Antonio urologist discovers combined anti-seizure drug and omega-3 may lower COVID-19 risks

September 9, 2024

  Ronald Rodriguez, MD, PhD, professor of medical education and urology at Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovers the combination of valproic acid and docosahexaenoic acid (DHA) may reduce the risk of contracting COVID-19 and lessen its severity, according to […]





UT Health San Antonio-led initiative receives multimillion-dollar support to improve heart health in South Texas

September 5, 2024

  A team of researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) are among four teams from across the United States that have been selected to launch community engagement centers thanks to a generous contribution from the American Heart Association and the Robert Wood Johnson Foundation. A total gift of $20 million […]




Clinical trial to investigate causes of diabetes, obesity in individuals with spinal cord injury and potential mitigatory effects of semaglutide

September 4, 2024

A first-of-its-kind investigation into the mechanisms behind diabetes and obesity in people with spinal cord injury and the antidiabetic and anti-obesity effects of semaglutide was recently approved for $3 million in National Institutes of Health funding. “This is one population in which they are susceptible to be more obese and having worse diabetes risk and […]